Could chloramphenicol be used against ESKAPE pathogens? A review of in vitro data in the literature from the 21st century

References

• Chopra I, Schofield C, Everett M, et al. Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement. Lancet Infect Dis 2008;8:133-9
   PubMed Web of Science ®Google Scholar
• Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 2008;197:1079-81
   PubMed Web of Science ®Google Scholar
• National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470-85
   PubMed Web of Science ®Google Scholar
• Ho J, Tambyah PA, Paterson DL. Multiresistant Gram-negative infections: a global perspective. Curr Opin Infect Dis 2010;23:546-53
   PubMed Web of Science ®Google Scholar
• Cornaglia G, Akova M, Amicosante G, et al. Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. Int J Antimicrob Agents 2007;29:380-8
   PubMed Web of Science ®Google Scholar
• Maltezou HC. Metallo-beta-lactamases in Gram-negative bacteria: introducing the era of pan-resistance? Int J Antimicrob Agents 2009;33:405; e1–7
   PubMedGoogle Scholar
• Livermore DM, Warner M, Mushtaq S, et al. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents 2011;37:415-19
   PubMed Web of Science ®Google Scholar
• Ehrlich J, Bartz QR, Smith RM, et al. Chloromycetin, a New Antibiotic From a Soil Actinomycete. Science 1947;106:417
   PubMed Web of Science ®Google Scholar
• Shalit I, Marks MI. Chloramphenicol in the 1980s. Drugs 1984;28:281-91
   PubMedGoogle Scholar
• Hargraves MM, Mills SD, Heck FJ. Aplastic anemia associated with administration of chloramphenicol. J Am Med Assoc 1952;119:1293-300
   PubMedGoogle Scholar
• Rich ML, Ritterhoff RJ, Hoffmann RJ. A fatal case of aplastic anemia following chloramphenicol (chloromycetin) therapy. Ann Intern Med 1950;33:1459-67
   PubMed Web of Science ®Google Scholar
• Udo EE, Al-Sweih N, John P, et al. Antibiotic resistance of enterococci isolated at a teaching hospital in Kuwait. Diagn Microbiol Infect Dis 2002;43:233-8
   PubMedGoogle Scholar
• Mirovic V. Antibiotic resistance in hospital strains of Enterococcus faecalis and Enterococcus faecium. Vojnosanit Pregl 2002;59:499-506
   PubMedGoogle Scholar
• Cereda RF, Gales AC, Silbert S, et al. Molecular typing and antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium in Brazil. Infect Control Hosp Epidemiol 2002;23:19-22
   PubMedGoogle Scholar
• Chen HY, Hill RL, Kirk M, et al. Differential antimicrobial susceptibility between human and chicken isolates of vancomycin-resistant and sensitive Enterococcus faecium. Int J Antimicrob Agents 2002;19:39-46
   PubMedGoogle Scholar
• Panesso D, Ospina S, Robledo J, et al. First characterization of a cluster of VanA-type glycopeptide-resistant Enterococcus faecium, Colombia. Emerg Infect Dis 2002;8:961-5
   PubMedGoogle Scholar
• Zhanel GG, Laing NM, Nichol KA, et al. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS). J Antimicrob Chemother 2003;52:382-8
   PubMed Web of Science ®Google Scholar
• Mutnick AH, Biedenbach DJ, Jones RN. Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis 2003;46:63-8
   PubMed Web of Science ®Google Scholar
• Arias CA, Reyes J, Zuniga M, et al. Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001-2002. J Antimicrob Chemother 2003;51:59-68
   PubMed Web of Science ®Google Scholar
• Udo EE, Al-Sweih N, Phillips OA, et al. Species prevalence and antibacterial resistance of enterococci isolated in Kuwait hospitals. J Med Microbiol 2003;52:163-8
   PubMed Web of Science ®Google Scholar
• Busani L, Del Grosso M, Paladini C, et al. Antimicrobial susceptibility of vancomycin-susceptible and -resistant enterococci isolated in Italy from raw meat products, farm animals, and human infections. Int J Food Microbiol 2004;97:17-22
   PubMedGoogle Scholar
• Titze-de-Almeida R, Rollo Filho M, Nogueira CA, et al. Molecular epidemiology and antimicrobial susceptibility of Enterococci recovered from Brazilian intensive care units. Braz J Infect Dis 2004;8:197-205
   Google Scholar
• Gould CV, Fishman NO, Nachamkin I, et al. Chloramphenicol resistance in vancomycin-resistant enterococcal bacteremia: impact of prior fluoroquinolone use? Infect Control Hosp Epidemiol 2004;25:138-45
   PubMedGoogle Scholar
• Lautenbach E, Gould CV, LaRosa LA, et al. Emergence of resistance to chloramphenicol among vancomycin-resistant enterococcal (VRE) bloodstream isolates. Int J Antimicrob Agents 2004;23:200-3
   PubMedGoogle Scholar
• Poeta P, Costa D, Rodrigues J, et al. Study of faecal colonization by vanA-containing Enterococcus strains in healthy humans, pets, poultry and wild animals in Portugal. J Antimicrob Chemother 2005;55:278-80
   PubMed Web of Science ®Google Scholar
• Quinones D, Goni P, Rubio MC, et al. Enterococci spp. isolated from Cuba: species frequency of occurrence and antimicrobial susceptibility profile. Diagn Microbiol Infect Dis 2005;51:63-7
   PubMedGoogle Scholar
• Silva AJ, Asserella RL, Bolados GN, et al. [Resistance to antimicrobial drugs in Enterococcus sp. strains isolated in hospitals of Northern Chile]. Rev Chilena Infectol 2006;23:226-31
   PubMedGoogle Scholar
• Nichol KA, Sill M, Laing NM, et al. Molecular epidemiology of urinary tract isolates of vancomycin-resistant Enterococcus faecium from North America. Int J Antimicrob Agents 2006;27:392-6
   PubMed Web of Science ®Google Scholar
• Klibi N, Gharbi S, Masmoudi A, et al. Antibiotic resistance and mechanisms implicated in clinical enterococci in a Tunisian hospital. J Chemother 2006;18:20-6
   PubMed Web of Science ®Google Scholar
• Deshpande LM, Fritsche TR, Moet GJ, et al. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 2007;58:163-70
   PubMed Web of Science ®Google Scholar
• Templer SP, Rohner P, Baumgartner A. Relation of Enterococcus faecalis and Enterococcus faecium isolates from foods and clinical specimens. J Food Prot 2008;71:2100-4
   PubMed Web of Science ®Google Scholar
• Guimaraes B, Barreto A, Radhouani H, et al. Genetic detection of extended-spectrum beta-lactamase-containing Escherichia coli isolates and vancomycin-resistant enterococci in fecal samples of healthy children. Microb Drug Resist 2009;15:211-16
   PubMedGoogle Scholar
• Barreto A, Guimaraes B, Radhouani H, et al. Detection of antibiotic resistant E. coli and Enterococcus spp. in stool of healthy growing children in Portugal. J Basic Microbiol 2009;49:503-12
   PubMedGoogle Scholar
• Kirdar S, Sener AG, Arslan U, et al. Molecular epidemiology of vancomycin-resistant Enterococcus faecium strains isolated from haematological malignancy patients in a research hospital in Turkey. J Med Microbiol 2010;59:660-4
   PubMed Web of Science ®Google Scholar
• Lopez M, Alvarez-Martinez MJ, Marco F, et al. Glycopeptide-resistant Enterococcus faecium. Analysis of the resistance genotype, virulence and genetic lines. Enferm Infecc Microbiol Clin 2013;31(1):10-14
   PubMedGoogle Scholar
• Manfredi R, Nanetti A, Valentini R, et al. Methicillin-resistant Staphylococcus aureus: a three-year epidemiological and microbiological survey of high-risk patients. Infez Med 2002;10:73-80
   PubMedGoogle Scholar
• Tahnkiwale SS, Roy S, Jalgaonkar SV. Methicillin resistance among isolates of Staphylococcus aureus: antibiotic sensitivity pattern & phage typing. Indian J Med Sci 2002;56:330-4
   PubMedGoogle Scholar
• Ma Y, Chen H, Yao L, et al. The change in sensitivity of methicillin-resistant Staphylococcus aureus to vancomycin. Zhonghua Nei Ke Za Zhi 2002;41:31-3
   PubMedGoogle Scholar
• Marchese A, Debbia EA, Tonoli E, et al. In vitro activity of thiamphenicol against multiresistant Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in Italy. J Chemother 2002;14:554-61
   PubMed Web of Science ®Google Scholar
• Hanumanthappa AR, Chandrappa NR, Rajasekharappa MG. Prevalence of methicillin-resistant Staphylococcus aureus in Karnataka. Indian J Pathol Microbiol 2003;46:129-32
   PubMedGoogle Scholar
• Gonlugur U, Akkurt I, Ozdemir L, et al. Antibiotic susceptibility patterns of respiratory isolates of Staphylococcus aureus in a Turkish university hospital. Acta Microbiol Pol 2003;52:143-8
   PubMedGoogle Scholar
• Hamze M, Dabboussi F, Daher W, et al. Antibiotic resistance of Staphylococcus aureus at north Lebanon: place of the methicillin resistance and comparison of detection methods. Pathol Biol (Paris) 2003;51:21-6
   PubMedGoogle Scholar
• Morrissey I, Burnett R, Viljoen L, et al. Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001/2002. J Infect 2004;49:109-14
   PubMed Web of Science ®Google Scholar
• Millan L, Cerda P, Rubio MC, et al. In vitro activity of telithromycin, quinupristin/dalfopristin, linezolid and comparator antimicrobial agents against Staphylococcus aureus clinical isolates. J Chemother 2004;16:230-7
   PubMed Web of Science ®Google Scholar
• Chi CY, Wong WW, Fung CP, et al. Epidemiology of community-acquired Staphylococcus aureus bacteremia. J Microbiol Immunol Infect 2004;37:16-23
   PubMedGoogle Scholar
• Panhotra BR, Saxena AK, Al-Mulhim AS. Chloramphenicol susceptible methicillin-resistant Staphylococcus aureus in eastern region of Saudi Arabia. Saudi Med J 2005;26:1149-51
   PubMed Web of Science ®Google Scholar
• Udo EE, Al-Sweih N, Mokaddas E, et al. Antibacterial resistance and their genetic location in MRSA isolated in Kuwait hospitals, 1994-2004. BMC Infect Dis 2006;6:168
   PubMed Web of Science ®Google Scholar
• Shittu AO, Lin J. Antimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in KwaZulu-Natal province, South Africa. BMC Infect Dis 2006;6:125
   PubMed Web of Science ®Google Scholar
• Cimolai N. Ocular methicillin-resistant Staphylococcus aureus infections in a newborn intensive care cohort. Am J Ophthalmol 2006;142:183-4
   PubMedGoogle Scholar
• Echaniz-Aviles G, Velazquez-Meza ME, Aires-de-Sousa M, et al. Molecular characterisation of a dominant methicillin-resistant Staphylococcus aureus (MRSA) clone in a Mexican hospital (1999-2003). Clin Microbiol Infect 2006;12:22-8
   PubMed Web of Science ®Google Scholar
• Mastouri M, Nour M, Ben Nejma M, et al. Antibiotics resistance of methicillin-resistant Staphylococcus aureus: detection of the first glycopeptides low sensibility strains in Tunisia. Pathol Biol (Paris) 2006;54:33-6
   PubMed Web of Science ®Google Scholar
• Mendes RE, Sader HS, Deshpande L, et al. Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers. Diagn Microbiol Infect Dis 2008;60:433-6
   PubMed Web of Science ®Google Scholar
• Tenover FC, McAllister S, Fosheim G, et al. Characterization of Staphylococcus aureus isolates from nasal cultures collected from individuals in the United States in 2001 to 2004. J Clin Microbiol 2008;46:2837-41
   PubMed Web of Science ®Google Scholar
• Tiwari HK, Sapkota D, Sen MR. High prevalence of multidrug-resistant MRSA in a tertiary care hospital of northern India. Infect Drug Resist 2008;1:57-61
   PubMedGoogle Scholar
• Chung HJ, Jeon HS, Sung H, et al. Epidemiological characteristics of methicillin-resistant Staphylococcus aureus isolates from children with eczematous atopic dermatitis lesions. J Clin Microbiol 2008;46:991-5
   PubMed Web of Science ®Google Scholar
• Shrestha B, Pokhrel BM, Mohapatra TM. Antibiotic susceptibility pattern of nosocomial isolates of Staphylococcus aureus in a tertiary care hospital, Nepal. JNMA J Nepal Med Assoc 2009;48:234-8
   PubMedGoogle Scholar
• Malik N, Butt T, Arfan ul B. Frequency and antimicrobial susceptibility pattern of methicillin-resistant Staphylococcus aureus. J Coll Physicians Surg Pak 2009;19:287-90
   PubMedGoogle Scholar
• Vourli S, Vagiakou H, Ganteris G, et al. High rates of community-acquired, Panton-Valentine leukocidin (PVL)- positive methicillin-resistant S. aureus (MRSA) infections in adult outpatients in Greece. Euro Surveill 2009;14:pii: 19089
   Google Scholar
• Wang Z, Cao B, Liu YM, et al. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study. Chin Med J (Engl) 2009;122:1283-8
   PubMed Web of Science ®Google Scholar
• Ojulong J, Mwambu TP, Joloba M, et al. Relative prevalence of methicillin-resistant Staphylococcus aureus and its susceptibility pattern in Mulago Hospital, Kampala, Uganda. Tanzan J Health Res 2009;11:149-53
   PubMedGoogle Scholar
• Idrees F, Jabeen K, Khan MS, et al. Antimicrobial resistance profile of methicillin-resistant Staphylococcal aureus from skin and soft tissue isolates. J Pak Med Assoc 2009;59:266-9
   PubMedGoogle Scholar
• Kaleem F, Usman J, Hassan A, et al. Sensitivity pattern of methicillin-resistant Staphylococcus aureus isolated from patients admitted in a tertiary care hospital of Pakistan. Iran J Microbiol 2010;2:143-6
   PubMedGoogle Scholar
• Pai V, Rao VI, Rao SP. Prevalence and antimicrobial susceptibility pattern of methicillin-resistant Staphylococcus aureus [MRSA] isolates at a tertiary care hospital in Mangalore, South India. J Lab Phys 2010;2:82-4
   Google Scholar
• Elsahn AF, Yildiz EH, Jungkind DL, et al. In vitro susceptibility patterns of methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus corneal isolates to antibiotics. Cornea 2010;29:1131-5
   PubMed Web of Science ®Google Scholar
• Taj Y, Abdullah FE, Kazmi SU. Current pattern of antibiotic resistance in Staphylococcus aureus clinical isolates and the emergence of vancomycin resistance. J Coll Physicians Surg Pak 2010;20:728-32
   PubMed Web of Science ®Google Scholar
• Mantadakis E, Maraki S, Michailidis L, et al. Antimicrobial susceptibility of Gram-positive cocci isolated from patients with conjunctivitis and keratitis in Crete, Greece. J Microbiol Immunol Infect 2011;46:41-7
   PubMedGoogle Scholar
• Walvick MD, Amato M. Ophthalmic methicillin-resistant Staphylococcus aureus infections: sensitivity and resistance profiles of 234 isolates. J Community Health 2011;36:1024-6
   PubMedGoogle Scholar
• Rubin JE, Chirino-Trejo M. Antimicrobial susceptibility of canine and human Staphylococcus aureus collected in Saskatoon, Canada. Zoonoses Public Health 2011;58:454-62
   PubMedGoogle Scholar
• Shahsavan S, Jabalameli L, Maleknejad P, et al. Molecular analysis and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in one of the hospitals of Tehran University of Medical Sciences: high prevalence of sequence type 239 (ST239) clone. Acta Microbiol Immunol Hung 2011;58:31-9
   PubMedGoogle Scholar
• Buzaid N, Elzouki AN, Taher I, et al. Methicillin-resistant Staphylococcus aureus (MRSA) in a tertiary surgical and trauma hospital in Benghazi, Libya. J Infect Dev Ctries 2011;5:723-6
   PubMedGoogle Scholar
• Nwankwo EO, Nasiru MS. Antibiotic sensitivity pattern of Staphylococcus aureus from clinical isolates in a tertiary health institution in Kano, Northwestern Nigeria. Pan Afr Med J 2011;8:4
   PubMedGoogle Scholar
• Koseoglu O, Sayin Kutlu S, Cevahir N. Prevalence and risk factors for methicillin-resistant Staphylococcus aureus colonization among outpatients undergoing hemodialysis treatment. Mikrobiyol Bul 2012;46:106-12
   PubMedGoogle Scholar
• Onanuga A, Awhowho GO. Antimicrobial resistance of Staphylococcus aureus strains from patients with urinary tract infections in Yenagoa, Nigeria. J Pharm Bioallied Sci 2012;4:226-30
   PubMedGoogle Scholar
• Lozano C, Porres-Osante N, Crettaz J, et al. Changes in genetic lineages, resistance, and virulence in clinical methicillin-resistant Staphylococcus aureus in a Spanish hospital. J Infect Chemother 2013;19:233-42
   PubMedGoogle Scholar
• Alvarez-Uria G, Reddy R. Prevalence and antibiotic susceptibility of community-associated methicillin-resistant Staphylococcus aureus in a rural area of India: is MRSA replacing methicillin-susceptible Staphylococcus aureus in the community? ISRN Dermatol 2012;2012:248951
   PubMedGoogle Scholar
• Teixeira MM, Araujo MC, Silva-Carvalho MC, et al. Emergence of clonal complex 5 (CC5) methicillin-resistant Staphylococcus aureus (MRSA) isolates susceptible to trimethoprim-sulfamethoxazole in a Brazilian hospital. Braz J Med Biol Res 2012;45:637-43
   PubMedGoogle Scholar
• Wackett A, Nazdryn A, Spitzer E, et al. MRSA rates and antibiotic susceptibilities from skin and soft tissue cultures in a suburban ED. J Emerg Med 2012;43:754-7
   PubMedGoogle Scholar
• Wang L, Liu Y, Yang Y, et al. Multidrug-resistant clones of community-associated methicillin-resistant Staphylococcus aureus isolated from Chinese children and the resistance genes to clindamycin and mupirocin. J Med Microbiol 2012;61:1240-7
   PubMed Web of Science ®Google Scholar
• Xiong Z, Zhu D, Wang F, et al. Investigation of extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli from China. Diagn Microbiol Infect Dis 2002;44:195-200
   PubMedGoogle Scholar
• Al-Zwaini EJ. Neonatal septicaemia in the neonatal care unit, Al-Anbar governorate, Iraq. East Mediterr Health J 2002;8:509-14
   PubMedGoogle Scholar
• Yamaguchi K, Ohno A, Kashitani F, et al. Activities of antimicrobial agents against 8,474 clinical isolates obtained from 37 medical institutions during 2000 in Japan. Jpn J Antibiot 2003;56:341-64
   PubMedGoogle Scholar
• Hamze M, Dabboussi F, Izard D. Enterobacterial susceptibility to antibiotics in northern Lebanon (1998-2001). Sante 2003;13:107-12
   PubMedGoogle Scholar
• Hasdemir UO, Chevalier J, Nordmann P, et al. Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey. J Clin Microbiol 2004;42:2701-6
   PubMed Web of Science ®Google Scholar
• De Champs C, Rich C, Chandezon P, et al. Factors associated with antimicrobial resistance among clinical isolates of Klebsiella pneumoniae: 1-year survey in a French university hospital. Eur J Clin Microbiol Infect Dis 2004;23:456-62
   PubMedGoogle Scholar
• Seid J, Asrat D. Occurrence of extended spectrum beta-lactamase enzymes in clinical isolates of Klebsiella species from Harar region, eastern Ethiopia. Acta Trop 2005;95:143-8
   PubMedGoogle Scholar
• Bii CC, Kose J, Taguchi H, et al. Pneumocystis jirovecii and microbiological findings in children with severe pneumonia in Nairobi, Kenya. Int J Tuberc Lung Dis 2006;10:1286-91
   PubMed Web of Science ®Google Scholar
• Soge OO, Adeniyi BA, Roberts MC. New antibiotic resistance genes associated with CTX-M plasmids from uropathogenic Nigerian Klebsiella pneumoniae. J Antimicrob Chemother 2006;58:1048-53
   PubMed Web of Science ®Google Scholar
• Gebre-Sealsssie S. Antimicrobial resistance patterns of clinical bacterial isolates in southwestern Ethiopia. Ethiop Med J 2007;45:363-70
   PubMedGoogle Scholar
• Isik F, Arslan U, Tuncer I. Short communication: extended-spectrum beta-lactamase production in Klebsiella pneumoniae strains isolated from blood cultures and their antibiotic susceptibilities. Mikrobiyol Bul 2008;42:131-6
   PubMedGoogle Scholar
• Cagnacci S, Gualco L, Roveta S, et al. Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak. J Antimicrob Chemother 2008;61:296-300
   PubMed Web of Science ®Google Scholar
• Nitzan O, Suponitzky U, Kennes Y, et al. Is chloramphenicol making a comeback? Isr Med Assoc J 2010;12:371-4
   PubMed Web of Science ®Google Scholar
• Rastegar Lari A, Azimi L, Rahbar M, et al. Phenotypic detection of Klebsiella pneumoniae carbapenemase among burns patients: first report from Iran. Burns 2013;39:174-6
   PubMed Web of Science ®Google Scholar
• Ahangarzadeh Rezaee M, Langarizadeh N, Aghazadeh M. First report of class 1 and class 2 integrons in multidrug-resistant Klebsiella pneumoniae isolates from northwest Iran. Jpn J Infect Dis 2012;65:256-9
   PubMed Web of Science ®Google Scholar
• Shi WF, Jiang JP, Mi ZH. Relationship between antimicrobial resistance and aminoglycoside-modifying enzyme gene expressions in Acinetobacter baumannii. Chin Med J (Engl) 2005;118:141-5
   PubMedGoogle Scholar
• Sung H, Choi SJ, Yoo S, et al. In vitro antimicrobial synergy against imipenem-resistant Acinetobacter baumannii. Korean J Lab Med 2007;27:111-17
   PubMedGoogle Scholar
• Huang LY, Chen TL, Lu PL, et al. Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan. Clin Microbiol Infect 2008;14:1010-19
   PubMed Web of Science ®Google Scholar
• Ricciardi R, Ricciardi AM, Danzi G. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii clinical isolates. Infez Med 2009;17:236-9
   PubMedGoogle Scholar
• Lin L, Ling BD, Li XZ. Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex. Int J Antimicrob Agents 2009;33:27-32
   PubMed Web of Science ®Google Scholar
• Bogiel T, Kwiecinska-Pirog J, Jachna-Sawicka K, et al. Carbapenem-resistant Acinetobacter baumannii strains. Med Dosw Mikrobiol 2010;62:119-26
   PubMedGoogle Scholar
• Shakibaie MR, Adeli S, Salehi MH. Antibiotic resistance patterns and extended-spectrum beta-lactamase production among Acinetobacter spp. isolated from an intensive care unit of a hospital in Kerman, Iran. Antimicrob Resist Infect Control 2012;1:1
   PubMedGoogle Scholar
• Loy AH, Tan AL, Lu PK. Microbiology of chronic suppurative otitis media in Singapore. Singapore Med J 2002;43:296-9
   PubMedGoogle Scholar
• Loureiro MM, de Moraes BA, Mendonca VL, et al. Pseudomonas aeruginosa: study of antibiotic resistance and molecular typing in hospital infection cases in a neonatal intensive care unit from Rio de Janeiro City, Brazil. Mem Inst Oswaldo Cruz 2002;97:387-94
   PubMed Web of Science ®Google Scholar
• Nyembue DT, Tshiswaka JM, Sabue MJ, et al. Bacteriology of chronic suppurative otitis media in Congolese children. Acta Otorhinolaryngol Belg 2003;57:205-8
   PubMedGoogle Scholar
• Ikem IC, Oginni LM, Bamgboye EA, et al. The bacteriology of open fractures in Ile-Ife, Nigeria. Niger J Med 2004;13:359-65
   PubMedGoogle Scholar
• Chalita MR, Hofling-Lima AL, Paranhos A Jr, et al. Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during a period of 15 years. Am J Ophthalmol 2004;137:43-51
   PubMed Web of Science ®Google Scholar
• Vedantham V, Nirmalan PK, Ramasamy K, et al. Clinico-microbiological profile and visual outcomes of post-traumatic endophthalmitis at a tertiary eye care center in South India. Indian J Ophthalmol 2006;54:5-10
   PubMedGoogle Scholar
• Anguzu JR, Olila D. Drug sensitivity patterns of bacterial isolates from septic post-operative wounds in a regional referral hospital in Uganda. Afr Health Sci 2007;7:148-54
   PubMedGoogle Scholar
• Gad GF, el-Domany RA, Ashour HM. Antimicrobial susceptibility profile of Pseudomonas aeruginosa isolates in Egypt. J Urol 2008;180:176-81
   PubMed Web of Science ®Google Scholar
• Ninkovic G, Dullo V, Saunders NC. Microbiology of otitis externa in the secondary care in United Kingdom and antimicrobial sensitivity. Auris Nasus Larynx 2008;35:480-4
   PubMedGoogle Scholar
• Pinna A, Usai D, Sechi LA, et al. An outbreak of post-cataract surgery endophthalmitis caused by Pseudomonas aeruginosa. Ophthalmology 2009;116:2321-6; e1–4
   PubMed Web of Science ®Google Scholar
• Lim KT, Yasin RM, Yeo CC, et al. Genetic fingerprinting and antimicrobial susceptibility profiles of Pseudomonas aeruginosa hospital isolates in Malaysia. J Microbiol Immunol Infect 2009;42:197-209
   PubMedGoogle Scholar
• Constantinou M, Jhanji V, Tao LW, et al. Clinical review of corneal ulcers resulting in evisceration and enucleation in elderly population. Graefes Arch Clin Exp Ophthalmol 2009;247:1389-93
   PubMedGoogle Scholar
• Goncalves Eda G, Reis Filho SA, Oliveira EG, et al. Bacterial infection in cutaneous leishmaniasis: bacterial pattern and sensitivity to antibiotics. Rev Soc Bras Med Trop 2009;42:219-21
   PubMedGoogle Scholar
• Rajput A, Saxena R, Singh KP, et al. Prevalence and antibiotic resistance pattern of metallo-beta-lactamase-producing Pseudomonas aeruginosa from burn patients–experience of an Indian tertiary care hospital. J Burn Care Res 2010;31:264-8
   PubMedGoogle Scholar
• Iwalokun BA, Oluwadun A, Akinsinde KA, et al. Bacteriologic and plasmid analysis of etiologic agents of conjunctivitis in Lagos, Nigeria. J Ophthalmic Inflamm Infect 2011;1:95-103
   PubMedGoogle Scholar
• Han HL, Huang Y, Zhang MM, et al. Clinical analysis of early postoperative pulmonary infection in children after living donor liver transplantation. Zhonghua Er Ke Za Zhi 2012;50:612-16
   PubMedGoogle Scholar
• Goncalves MO, Coutinho-Filho WP, Pimenta FP, et al. Periodontal disease as reservoir for multi-resistant and hydrolytic enterobacterial species. Lett Appl Microbiol 2007;44:488-94
   PubMed Web of Science ®Google Scholar
• Chevalier J, Mulfinger C, Garnotel E, et al. Identification and evolution of drug efflux pump in clinical Enterobacter aerogenes strains isolated in 1995 and 2003. PLoS One 2008;3:e3203
   Google Scholar
• Ogunsalu C, Daisley H, Akpaka PE. Prevalence and antimicrobial susceptibility pattern of pathogens isolated from patients with juvenile periodontitis in Jamaica: a prospective multi-centre study of 15 cases over a 15-year period. West Indian Med J 2011;60:235-9
   PubMedGoogle Scholar
• Kaplan SL, Mason EO Jr. In vitro synergy of ampicillin and chloramphenicol against Gram-negative bacteria. Pediatr Pharmacol (New York) 1981;1:305-11
   PubMedGoogle Scholar
• Weeks JL, Mason EO Jr, Baker CJ. Antagonism of ampicillin and chloramphenicol for meningeal isolates of group B streptococci. Antimicrob Agents Chemother 1981;20:281-5
   PubMedGoogle Scholar
• Rocco V, Overturf G. Chloramphenicol inhibition of the bactericidal effect of ampicillin against Haemophilus influenzae. Antimicrob Agents Chemother 1982;21:349-51
   PubMedGoogle Scholar
• Asmar BI, Dajani AS. Ampicillin-chloramphenicol interaction against enteric Gram-negative organisms. Pediatr Infect Dis 1983;2:39-42
   PubMedGoogle Scholar
• Guggenbichler JP. Bactericidal action of chloramphenicol and synergism with beta-lactam antibiotics. Padiatr Padol 1983;18:11-20
   PubMedGoogle Scholar
• Lapointe JR, Lavallee C, Michaud A, et al. In vitro comparison of ampicillin-chloramphenicol and ampicillin-cefotaxime against 284 Haemophilus isolates. Antimicrob Agents Chemother 1986;29:594-7
   PubMedGoogle Scholar
• Nizou JY, Cavallo JD, Crenn Y, et al. In vitro bactericidal activity of seven antibiotics and four combinations against Neisseria meningitidis. Pathol Biol (Paris) 1994;42:393-8
   PubMedGoogle Scholar
• Messick CR, Pendland SL. In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococci. Diagn Microbiol Infect Dis 1997;29:203-5
   PubMedGoogle Scholar
• Asmar BI, Prainito M, Dajani AS. Antagonistic effect of chloramphenicol in combination with cefotaxime or ceftriaxone. Antimicrob Agents Chemother 1988;32:1375-8
   PubMedGoogle Scholar
• Brown TH, Alford RH. Antagonism by chloramphenicol of broad-spectrum beta-lactam antibiotics against Klebsiella pneumoniae. Antimicrob Agents Chemother 1984;25:405-7
   PubMedGoogle Scholar
• Malik M, Lu T, Zhao X, et al. Lethality of quinolones against Mycobacterium smegmatis in the presence or absence of chloramphenicol. Antimicrob Agents Chemother 2005;49:2008-14
   PubMedGoogle Scholar
• Kawakami M, Nagai Y, Shimizu S, et al. Anti-microbial effect of combinations of colistin methanesulfonate and chloramphenicol. II. In vivo effect. J Antibiot (Tokyo) 1971;24:892-5
   PubMedGoogle Scholar
• Perea EJ, Torres MA, Borobio MV. Synergism of fosfomycin-ampicillin and fosfomycin-chloramphenicol against Salmonella and Shigella. Antimicrob Agents Chemother 1978;13:705-9
   PubMedGoogle Scholar
• Klastersky J, Husson M. Bactericidal activity of the combinations of gentamicin with clindamycin or chloramphenicol against species of Escherichia coli and Bacteroides fragilis. Antimicrob Agents Chemother 1977;12:135-8
   PubMedGoogle Scholar
• Sanderson PJ. Gentamicin and chloramphenicol in neonatal meningitis. Lancet 1978;2:210
   PubMedGoogle Scholar
• Michel J, Jacobs J, Sacks T. Bactericidal synergistic effect due to chloramphenicol-induced inhibition of staphylococcal penicillinase. Chemotherapy 1977;23:32-6
   PubMed Web of Science ®Google Scholar
• Feldman WE. Effect of ampicillin and chloramphenicol against Haemophilus influenzae. Pediatrics 1978;61:406-9
   PubMedGoogle Scholar
• Haley EC Jr, Costello GT, Rodeheaver GT, et al. Treatment of experimental brain abscess with penicillin and chloramphenicol. J Infect Dis 1983;148:737-44
   PubMed Web of Science ®Google Scholar
• Winslow DL, Damme J, Dieckman E. Delayed bactericidal activity of beta-lactam antibiotics against Listeria monocytogenes: antagonism of chloramphenicol and rifampin. Antimicrob Agents Chemother 1983;23:555-8
   PubMedGoogle Scholar
• Kasten MJ. Clindamycin, metronidazole, and chloramphenicol. Mayo Clin Proc 1999;74:825-33
   PubMed Web of Science ®Google Scholar
• Norris AH, Reilly JP, Edelstein PH, et al. Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. Clin Infect Dis 1995;20:1137-44
   PubMed Web of Science ®Google Scholar
• Lautenbach E, Schuster MG, Bilker WB, et al. The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus. Clin Infect Dis 1998;27:1259-65
   PubMed Web of Science ®Google Scholar
• Safdar A, Bryan CS, Stinson S, et al. Prosthetic valve endocarditis due to vancomycin-resistant Enterococcus faecium: treatment with chloramphenicol plus minocycline. Clin Infect Dis 2002;34:E61-3
   PubMedGoogle Scholar
• Schwarz S, Kehrenberg C, Doublet B, Cloeckaert A. Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol Rev 2004;28:519-42
   PubMed Web of Science ®Google Scholar
• Kawakami M, Nagai Y, Shimizu S, et al. Anti-microbial effect of combinations of colistin methanesulfonate and chloramphenicol. I. In vitro effect. J Antibiot (Tokyo) 1971;24:884-91
   PubMedGoogle Scholar
• Feder HM Jr, Osier C, Maderazo EG. Chloramphenicol: a review of its use in clinical practice. Rev Infect Dis 1981;3:479-91
   PubMedGoogle Scholar